imatinib_mesylate  - Removal Estimates

💊 imatinib_mesylate 

imatinib_mesylate  Dialyzability By Different Modalities

MW: 493.615
Protein Binding: 95%%
Vd: N/A

📊 Removal Estimates

Estimates based on drug properties and standard treatment parameters.

🩸

Hemodialysis

10.8 mL/min
Poorly Dialyzable
Minimal removal expected. Half-life: 18 h (imatinib). No supplementation needed.
Data Used:
✅ protein_binding, molar_mass, mw_factor, half_life
⚠️ Missing: vd
Free fraction: 0.05 Mw factor: 1 Vd factor: 0.8 Hl factor: 1 Half life: 18 h (imatinib) Half life category: Long (12-24h)
🫀

Peritoneal Dialysis

0.8 mL/min
Low PD Clearance
Minimal removal expected. No supplementation needed. Half-life: 18 h (imatinib).
Data Used:
✅ protein_binding, molar_mass, half_life
Free fraction: 0.05 Half life: 18 h (imatinib) Half life category: Long (12-24h)
🔄

Plasmapheresis (TPE)

Potential Risk (Vd Unknown)
High protein binding suggests possible removal. Vd data needed for accurate assessment.
Data Used:
✅ protein_binding, half_life
⚠️ Missing: vd
Half life: 18 h (imatinib) Half life category: Long (12-24h)
🧪

Hemoadsorption

Cannot Assess
Vd data required for hemoadsorption effectiveness assessment.
Data Used:
✅ half_life
⚠️ Missing: vd
Half life: 18 h (imatinib) Half life category: Long (12-24h)

📋 Summary of Estimates

Modality Clearance/Value Half-Life Classification Data Quality
Hemodialysis 10.8 mL/min 18 h (imatinib) Poorly Dialyzable Partial Data
Peritoneal Dialysis 0.8 mL/min 18 h (imatinib) Low PD Clearance Complete Data
Plasmapheresis (TPE) Potential Risk (Vd Unknown) 18 h (imatinib) N/A Partial Data
Hemoadsorption Cannot Assess 18 h (imatinib) N/A Partial Data

📌 Important Notes

Back to Drug Details